Document is current
Any future updates will be listed below
-
Authors
,
Mayo-Wilson, Evan http://orcid.org/0000-0001-6126-2459
Heyward, James
Keyes, Anthony
Reynolds, Jesse
White, Sarah
Atri, Nidhi
Alexander, G. Caleb
Omar, Audrey
Ford, Daniel E.
-
Funding
Funding for this research was provided by:
U.S. Food and Drug Administration (U01 FD004977-01)
National Center for Research Resources and the National Center for Advancing Translational Sciences (UL1TR001079)
- License Information
-
More Information
Article History
Received: 6 December 2017
Accepted: 22 March 2018
First Online: 2 May 2018
Ethics approval
: The Johns Hopkins School of Public Health Institutional Review Board (FWA#0000287) determined that the study was not human subjects research (00007429).
: AK, JR, and SW completed the survey on behalf of their organizations.AK chairs the National Clinical Trials Registration and Results Reporting Taskforce Survey Subcommittee. AK and SW co-chair the National Clinical Trials Registration and Results Reporting Taskforce. AK and NA are Protocol Registration and Results System (PRS) administrators for the “Johns Hopkins University” account. JR and AO are PRS administrators for the “Yale University” account. When we conducted this study, SW was a PRS administrator for the “Brigham and Women’s Hospital,” “Massachusetts General Hospital,” and “McLean Hospital” accounts. SW is currently the Executive Director of the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
